Evidence map›Paper›PMID 40304064›Full record

ArticleHaematologica2025

Clonality analysis of HTLV-1-infected cells enhances prognostic precision in smoldering adult T-cell leukemia/ lymphoma.

Masumichi Saito, Tomoo Sato, Hiroo Hasegawa, Kenichiro Tanabe, Hazuka Yoshida-Furihata, Erika Horibe, Ariella Coler-Reilly, Naomi Nojiri, Shunsuke Yamauchi, Makoto Nakashima and 16 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Haematologica, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

26 authors.

Masumichi SaitoCenter for Emergency Preparedness and Response, National Institute of Infectious Diseases, Tokyo, Japan; Department of Virology II, National Institute of Infectious Diseases, Tokyo, Japan; Department of Rare Diseases Research, Institute of Medical Science, St. Marianna University School of Medicine, Kanagawa. saitomas@niid.go.jp.
Tomoo SatoDepartment of Rare Diseases Research, Institute of Medical Science, St. Marianna University School of Medicine, Kanagawa, Japan; Department of Neurology, St. Marianna University School of Medicine, Kanagawa.
Hiroo HasegawaDepartment of Laboratory Medicine, Nagasaki University Hospital, Nagasaki.
Kenichiro TanabePathophysiology and Bioregulation, St. Marianna University Graduate School of Medicine, Kanagawa.
Hazuka Yoshida-FurihataCenter for Emergency Preparedness and Response, National Institute of Infectious Diseases, Tokyo.
Erika HoribeDepartment of Rare Diseases Research, Institute of Medical Science, St. Marianna University School of Medicine, Kanagawa.
Ariella Coler-ReillyMedical Scientist Training Program, Washington University School of Medicine, St. Louis, MO, United States.
Naomi NojiriCenter for Emergency Preparedness and Response, National Institute of Infectious Diseases, Tokyo.
Shunsuke YamauchiDepartment of Laboratory Medicine, Nagasaki University Hospital, Nagasaki.
Makoto NakashimaDepartment of Rare Diseases Research, Institute of Medical Science, St. Marianna University School of Medicine, Kanagawa.
Natsumi ArayaDepartment of Rare Diseases Research, Institute of Medical Science, St. Marianna University School of Medicine, Kanagawa.
Naoko YagishitaDepartment of Rare Diseases Research, Institute of Medical Science, St. Marianna University School of Medicine, Kanagawa.
Kenichiro TakahashiCenter for Emergency Preparedness and Response, National Institute of Infectious Diseases, Tokyo.
Daisuke SasakiDepartment of Laboratory Medicine, Nagasaki University Hospital, Nagasaki.
Yasuko SagaraJapanese Red Cross Kyushu Block Blood Center, Fukuoka.
Kaoru UchimaruLaboratory of Tumor Cell Biology, Department of Computational Biology and Medical Sciences, Graduate School of Frontier Sciences, The University of Tokyo, Tokyo, Japan; Department of Hematology/Oncology, IMSUT Hospital, The Institute of Medical Science, The University of Tokyo, Tokyo.
Atae UtsunomiyaImamura General Hospital, Kagoshima.
Koh Ki-RyangDepartment of Hematology, Osaka General Hospital of West Japan Railway Company, Osaka.
Takeharu KatoDepartment of Hematology, Nagasaki University Hospital, Nagasaki.
Hidehiro ItonagaTransfusion and Cell Therapy Unit, Nagasaki University Hospital, Nagasaki.
Yasushi MiyazakiDepartment of Hematology, Nagasaki University Hospital, Nagasaki, Japan; Atomic Bomb Disease and Hibakusha Medicine Unit, Atomic Bomb Disease Institute, Nagasaki University, Nagasaki.
Katsunori YanagiharaDepartment of Laboratory Medicine, Nagasaki University Hospital, Nagasaki.
Kumi OshimaDepartment of Hematology and Oncology, St. Marianna University Graduate School of Medicine, Kanagawa.
Ayako AraiDepartment of Hematology and Oncology, St. Marianna University Graduate School of Medicine, Kanagawa.
Toshiki WatanabeDepartment of Hematology and Oncology, St. Marianna University Graduate School of Medicine, Kanagawa.
Yoshihisa YamanoDepartment of Rare Diseases Research, Institute of Medical Science, St. Marianna University School of Medicine, Kanagawa, Japan; Department of Neurology, St. Marianna University School of Medicine, Kanagawa. yyamano@marianna-u.ac.jp.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID40304064
PMCPMC12485313

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.